MedNation Stock Forecast for 2023 - 2025 - 2030

Updated on 05/02/2024

Stock Rating
0
Price Target
0.00€
Consensus
-
Downside
-100.00%
Analysts
0
Stock Rating
0
Downside
-100.00%
Analysts
0
Price Target
0.00€
-

MedNation Fair Value Forecast for 2023 - 2025 - 2030

In the last year, MedNation has seen a decline in its Price, from 5.40€ to 0.00€ – a 100.00% decrease. For the next year, analysts predict that Fair Value will reach 0.00€ – an increase of 100.00%. Over the next six years, experts believe that MedNation's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
0.00€
2026 Fair Value Forecast
0.00€
2027 Fair Value Forecast
0.00€
2028 Fair Value Forecast
0.00€
2029 Fair Value Forecast
0.00€
2030 Fair Value Forecast
0.00€

MedNation Revenue Forecast for 2023 - 2025 - 2030

In the last two years, MedNation's Revenue has grown by 3.24%, rising from 36.37€M to 37.55€M. According to the 0 analysts polled, in the next year, MedNation's Revenue will fall by 1.82%, reaching 36.87€M. By 2030, professionals believe that MedNation's Revenue will have decreased by 1.80%, falling to 36.87€M.

2023 Rev Forecast
0.04€B
2024 Rev Forecast
0.04€B
2025 Rev Forecast
0.04€B
2026 Rev Forecast
0.04€B
2027 Rev Forecast
0.04€B
2028 Rev Forecast
0.04€B
2029 Rev Forecast
0.04€B
2030 Rev Forecast
0.04€B

MedNation Dividend per Share Forecast for 2023 - 2025 - 2030

MedNation Free Cash Flow Forecast for 2023 - 2025 - 2030

MedNation EBITDA Forecast for 2023 - 2025 - 2030

MedNation's EBITDA has seen growth In the last two years, going from 1.45€M to 2.55€M – a gain of 75.86% In the following year, 0 experts forecast MedNation's EBITDA will decrease by 27.16%, to 1.86€M. In 2030, professionals predict that MedNation's EBITDA will decrease by 23.49%, to 1.95€M.

2023 EBITDA Forecast
0.00€B
2024 EBITDA Forecast
0.00€B
2025 EBITDA Forecast
0.00€B
2026 EBITDA Forecast
0.00€B
2027 EBITDA Forecast
0.00€B
2028 EBITDA Forecast
0.00€B
2029 EBITDA Forecast
0.00€B
2030 EBITDA Forecast
0.00€B

MedNation EBIT Forecast for 2023 - 2025 - 2030

In the last two years, EBIT for MedNation has grown by 374.47%, going from -470.00€k to 1.29€M. According to 0 major analysts, MedNation's EBIT will fall by 121.00% in the next year, reaching -270.86€k. Professionals believe that By 2030, MedNation's EBIT will fall to -2.59€M– a 300.53% decrease from its current value.

2023 EBIT Forecast
-270857.00€
2024 EBIT Forecast
-608994.88€
2025 EBIT Forecast
-1338794.04€
2026 EBIT Forecast
-3419458.49€
2027 EBIT Forecast
-1471734.93€
2028 EBIT Forecast
-1555035.13€
2029 EBIT Forecast
-1897816.71€
2030 EBIT Forecast
-2586850.69€

MedNation EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last year, MedNation has seen a decline in its EPS, from 0.36€ to 0.00€ – a 100.00% decrease. For the next year, analysts predict that EPS will reach 0.00€ – an increase of 100.00%. Over the next six years, experts believe that MedNation's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
0.00€
2026 EPS Forecast
0.00€
2027 EPS Forecast
0.00€
2028 EPS Forecast
0.00€
2029 EPS Forecast
0.00€
2030 EPS Forecast
0.00€